Warfarin for Dilated Cardiomyopathy

Joel Tsevat, Mark H. Eckman, Robert A. Mcnutt and Stephen G. Pauker

Medical Decision Making, 1989, vol. 9, issue 3, 162-169

Abstract: Although current recommendations for the treatment of dilated cardiomyopathy include long- term anticoagulation to diminish the likelihood of systemic embolization, there have been no clinical trials examining the effectiveness of anticoagulation in preventing systemic emboli zation in these patients. Furthermore, those recommendations do not address the issue of the quality of life associated with long-term warfarin therapy. Using decision analysis, the authors examined the benefits and risks of long-term anticoagulation for patients 35 to 75 years of age who have dilated cardiomyopathy. The results show that anticoagulant therapy increases quality-adjusted life expectancy by 76 to 128 days, depending on the patient's age. Sensitivity analysis, however, demonstrates that the outcome is dependent on the disutility associated with long-term warfarin therapy. Interestingly, anticoagulation exerts most of its benefit by preventing pulmonary embolization, not systemic embolization. The authors conclude that the current recommendation to anticoagulate these patients, although probably correct for many patients, should take into consideration the change in lifestyle imposed by long-term anticoagulant therapy. For some patients, the benefit may not outweigh the sac rifice.

Keywords: Key words: anticoagulation; dilated cardiomyopathy; warfarin; decision analysis; quality of life. (Med Decis Making 1989; 9:162-169) (search for similar items in EconPapers)
Date: 1989
References: View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://journals.sagepub.com/doi/10.1177/0272989X8900900303 (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:sae:medema:v:9:y:1989:i:3:p:162-169

DOI: 10.1177/0272989X8900900303

Access Statistics for this article

More articles in Medical Decision Making
Bibliographic data for series maintained by SAGE Publications ().